call Toll Free (US/Canada) : +1 866 658 6826 | call +1 425 320 4776 | call (UK) : +44 1865 60 0662 | email info(@)blueweaveconsulting.com
Home | About Us | Career | Services | Blog | Contact Us
Blueweave
Global Pneumonia Therapeutics Market Bwc20135
Inquire Before Buying Request for Sample

Global Pneumonia Therapeutics Market Bwc20135

Home Healthcare And Pharmaceutical Global Pneumonia Therapeutics Market Bwc20135

SPECIAL OFFER : 25% Super Discount For All !

Global Pneumonia Therapeutics Market- Industry Size, Share, Trend Analysis, Outlook, Growth, Opportunity and Forecast, 2018-2028, Segmented By Therapeutics (Prevention Vaccine, Treatment Drugs and Oxygen Therapy), By Drug Class (Antibacterial Drugs (Macrolide, Quinolones, and Others), Antiviral Drugs and Antifungal Drugs), By Age Group (Paediatric, Adult and Geriatric), By Infection Type (Hospital-acquired Pneumonia [HAP], Community-acquired Pneumonia [CAP] and Ventilator-associated Pneumonia [VAP]), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region (North America, Europe, the Asia-Pacific, the Middle-East & Africa, and Latin America)

  • Published Date: January 2022
  • Report ID: BWC20135
  • Available Format: PDF
  • Page: 226

  1. Research Framework
    1. Research Objective
    2. Product Overview
    3. Market Segmentation
  2. Research Methodology
    1. Qualitative Research
      1. Primary & Secondary Research
    2. Quantitative Research
    3. Market Breakdown & Data Triangulation
      1. Primary & Secondary Research End-use Vendors  
      2. Secondary Research
      3. Primary Research
    4. Breakdown of Primary Research Respondents, By Region
    5. Assumption & Limitation
  3. Executive Summary
  4. Global Pneumonia Therapeutics Market Insights
    1. Industry Value Chain Analysis
    2. DROC Analysis
      1. Growth Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
    3. Porter’s Five Forces Analysis
      1. Bargaining End-use Industry of Suppliers
      2. Bargaining End-use Industry of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
    4. Recent Development/ Technological Advancement
    5. Regulatory Insights
  5. Global Pneumonia Therapeutics Market Overview
    1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Therapeutics
        1. Prevention Vaccine
        2. Treatment Drugs
        3. Oxygen Therapy
      2. By Drug Class
        1. Antibacterial Drugs
          1. Macrolide
          2. Quinolones
          3. Others
        2. Antiviral Drugs
        3. Antifungal Drugs
      3. By Age Group
        1. Paediatric
        2. Adult
        3. Geriatric
      4. By Infection Type
        1. Hospital-acquired Pneumonia [HAP]
        2. Community-acquired Pneumonia [CAP]
        3. Ventilator-associated Pneumonia [VAP]
      5. By Distribution Channel
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      6. By Region

               5.2.3.1. North America

5.2.3.2. Europe

               5.2.3.3. Asia-Pacific

5.2.3.4. Latin America

               5.2.3.5. Middle East and Africa

  1. North Pneumonia Therapeutics Market
    1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Therapeutics
      2. By Drug Class
      3. By Age Group
      4. By Infection Type
      5. By Distribution Channel
      6. By Country
        1. U.S.
        2. Canada
  2. Europe Pneumonia Therapeutics Market 
    1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Therapeutics
      2. By Drug Class
      3. By Age Group
      4. By Infection Type
      5. By Distribution Channel
      6. By Country
        1. France
        2. Germany
        3. Italy
        4. Spain
        5. Rest of Europe
  3. The Asia-Pacific (APAC) Pneumonia Therapeutics Market 
    1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Therapeutics
      2. By Drug Class
      3. By Age Group
      4. By Infection Type
      5. By Distribution Channel
      6. By Country
        1. Japan
        2. China
        3. India
        4. South Korea
        5. Rest of APAC
  4. Latin America Pneumonia Therapeutics Market
    1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Therapeutics
      2. By Drug Class
      3. By Age Group
      4. By Infection Type
      5. By Distribution Channel
      6. By Country
        1. Brazil
        2. Argentina
        3. Mexico
        4. Rest of Latin America
  5. The Middle East & Africa (MEA) Pneumonia Therapeutics Market
    1. Market Size & Forecast by Value, 2018-2028
      1. By Value (USD Million)
    2. Market Share & Forecast
      1. By Therapeutics
      2. By Drug Class
      3. By Age Group
      4. By Infection Type
      5. By Distribution Channel
      6. By Country
        1. South Africa
        2. Saudi Arabia
        3. U.A.E.
        4. Rest of MEA
  6. Competitive Landscape
    1. List of Key Players and their Offerings
    2. Company Market Share Analysis, 2021
    3. Competitive Benchmarking, By Operating Parameters
  7. Impact of Covid-19 across Global Pneumonia Therapeutics Market
  8. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

 

    1. Merck & Co, Inc
    2. Sanofi SA
    3. AstraZeneca plc
    4. Eli Lilly and Company
    5. Teva Pharmaceutical Industries Ltd
    6. Abbvie Inc
    7. Novartis International AG
    8. Abbott Laboratories
    9. Bayer AG
    10. Pfizer Inc
    11. GlaxoSmithKline Plc
    12. Lupin Pharmaceuticals, Inc
  2. Key Strategic Recommendations

 

*Financial details of unlisted companies will be available as per data availability in the final deliverable

**The segmentation and the companies are subjected to modifications based on the in-depth secondary for the final deliverable

 

List of figures

Fig 1: Global Pneumonia Therapeutics Market Segmentation

Fig 2: Global Pneumonia Therapeutics Market Size, By Value (USD Million)

Fig 3: Global Pneumonia Therapeutics Market Share (%), By Distribution Channel, By Value (in %), 2021

Fig 4: Global Pneumonia Therapeutics Market Industry Value Chain Analysis

Fig 5: Global Pneumonia Therapeutics Market Industry Players

Fig 6: Global Pneumonia Therapeutics Market Share: Market Share Analysis, 2021

Fig 7: Porters Five Forces Analysis

Fig 8: Global Pneumonia Therapeutics Market Size, By Value (USD Million), 2018-2028

Fig 9: Global Pneumonia Therapeutics Market Share (%), By Therapeutics, By Value, 2018-2028

Fig 10: Global Pneumonia Therapeutics Market Share (%), By Drug class, By Value, 2018-2028

Fig 11: Global Pneumonia Therapeutics Market Share (%), By Drug Class, For Antibacterial Drugs, By Value, 2018-2028

Fig 12: Global Pneumonia Therapeutics Market Share (%), By Age Group, By Value, 2018-2028

Fig 13: Global Pneumonia Therapeutics Market Share (%), By Infection Type, By Value, 2018-2028

Fig 14: Global Pneumonia Therapeutics Market Share (%), By Distribution Channel, By Value, 2018-2028

Fig 15: Global Pneumonia Therapeutics Market Share (%), By Region, By Value, 2018-2028

Fig 16: North America Pneumonia Therapeutics Market Size, By Value (USD Million), 2018-2028

Fig 17: North America Pneumonia Therapeutics Market Share (%), By Therapeutics, By Value, 2018-2028

Fig 18:  North America Pneumonia Therapeutics Market Share (%), By Drug class, By Value, 2018-2028

Fig 19:  North America Pneumonia Therapeutics Market Share (%), By Drug Class, For Antibacterial Drugs, By Value, 2018-2028

Fig 20:  North America Pneumonia Therapeutics Market Share (%), By Age Group, By Value, 2018-2028

Fig 21:  North America Pneumonia Therapeutics Market Share (%), By Infection Type, By Value, 2018-2028

Fig 22:  North America Pneumonia Therapeutics Market Share (%), By Distribution Channel, By Value, 2018-2028

Fig 23:  North America Pneumonia Therapeutics Market Share (%), By Country, By Value, 2018-2028

Fig 24: Europe Pneumonia Therapeutics Market Size, By Value (USD Million), 2018-2028

Fig 25: Europe Pneumonia Therapeutics Market Share (%), By Therapeutics, By Value, 2018-2028

Fig 26:  Europe Pneumonia Therapeutics Market Share (%), By Drug class, By Value, 2018-2028

Fig 27:  Europe Pneumonia Therapeutics Market Share (%), By Drug Class, For Antibacterial Drugs, By Value, 2018-2028

Fig 28:  Europe Pneumonia Therapeutics Market Share (%), By Age Group, By Value, 2018-2028

Fig 29:  Europe Pneumonia Therapeutics Market Share (%), By Infection Type, By Value, 2018-2028

Fig 30:  Europe Pneumonia Therapeutics Market Share (%), By Distribution Channel, By Value, 2018-2028

Fig 31:  Europe Pneumonia Therapeutics Market Share (%), By Country, By Value, 2018-2028

Fig 32: Asia-Pacific Pneumonia Therapeutics Market Size, By Value (USD Million), 2018-2028

Fig 33: Asia-Pacific Pneumonia Therapeutics Market Share (%), By Therapeutics, By Value, 2018-2028

Fig 34:  Asia-Pacific Pneumonia Therapeutics Market Share (%), By Drug class, By Value, 2018-2028

Fig 35:  Asia-Pacific Pneumonia Therapeutics Market Share (%), By Drug Class, For Antibacterial Drugs, By Value, 2018-2028

Fig 36:  Asia-Pacific Pneumonia Therapeutics Market Share (%), By Age Group, By Value, 2018-2028

Fig 37:  Asia-Pacific Pneumonia Therapeutics Market Share (%), By Infection Type, By Value, 2018-2028

Fig 38:  Asia-Pacific Pneumonia Therapeutics Market Share (%), By Distribution Channel, By Value, 2018-2028

Fig 39:  Asia-Pacific Pneumonia Therapeutics Market Share (%), By Country, By Value, 2018-2028

Fig 40: Latin America Pneumonia Therapeutics Market Size, By Value (USD Million), 2018-2028

Fig 41: Latin America Pneumonia Therapeutics Market Share (%), By Therapeutics, By Value, 2018-2028

Fig 42:  Latin America Pneumonia Therapeutics Market Share (%), By Drug class, By Value, 2018-2028

Fig 43:  Latin America Pneumonia Therapeutics Market Share (%), By Drug Class, For Antibacterial Drugs, By Value, 2018-2028

Fig 44:  Latin America Pneumonia Therapeutics Market Share (%), By Age Group, By Value, 2018-2028

Fig 45:  Latin America Pneumonia Therapeutics Market Share (%), By Infection Type, By Value, 2018-2028

Fig 46:  Latin America Pneumonia Therapeutics Market Share (%), By Distribution Channel, By Value, 2018-2028

Fig 47:  Latin America Pneumonia Therapeutics Market Share (%), By Country, By Value, 2018-2028

Fig 48: Middle East & Africa Pneumonia Therapeutics Market Size, By Value (USD Million), 2018-2028

Fig 49: Middle East & Africa Pneumonia Therapeutics Market Share (%), By Therapeutics, By Value, 2018-2028

Fig 50:  Middle East & Africa Pneumonia Therapeutics Market Share (%), By Drug class, By Value, 2018-2028

Fig 51:  Middle East & Africa Pneumonia Therapeutics Market Share (%), By Drug Class, For Antibacterial Drugs, By Value, 2018-2028

Fig 52:  Middle East & Africa Pneumonia Therapeutics Market Share (%), By Age Group, By Value, 2018-2028

Fig 53:  Middle East & Africa Pneumonia Therapeutics Market Share (%), By Infection Type, By Value, 2018-2028

Fig 54:  Middle East & Africa Pneumonia Therapeutics Market Share (%), By Distribution Channel, By Value, 2018-2028

Fig 55:  Middle East & Africa Pneumonia Therapeutics Market Share (%), By Country, By Value, 2018-2028

 

List of Tables

 

Table 1: Global Pneumonia Therapeutics Market Size (USD Million), By Therapeutics, By Value, 2018-2028

Table 2: Global Pneumonia Therapeutics Market Size (USD Million), By Drug Class, By Value, 2018-2028

Table 3: Global Pneumonia Therapeutics Market Size (USD Million), By Drug Class, For Antibacterial Drugs, By Value, 2018-2028

Table 4: Global Pneumonia Therapeutics Market Size (USD Million), By Age Group, By Value, 2018-2028

Table 5: Global Pneumonia Therapeutics Market Size (USD Million), By Infection Type, By Value, 2018-2028

Table 6: Global Pneumonia Therapeutics Market Size (USD Million), By Distribution Channel, By Value, 2018-2028

Table 7: Global Pneumonia Therapeutics Market Size. By Region, By Value (USD Million), 2018-2028

Table 8:  North America Pneumonia Therapeutics Market Size (USD Million), By Therapeutics, By Value, 2018-2028

Table 9:   North America Pneumonia Therapeutics Market Size (USD Million), By Drug Class, By Value, 2018-2028

Table 10:   North America Pneumonia Therapeutics Market Size (USD Million), By Drug Class, For Antibacterial Drugs, By Value, 2018-2028

Table 11:   North America Pneumonia Therapeutics Market Size (USD Million), By Age Group, By Value, 2018-2028

Table 12:   North America Pneumonia Therapeutics Market Size (USD Million), By Infection Type, By Value, 2018-2028

Table 13:   North America Pneumonia Therapeutics Market Size (USD Million), By Distribution Channel, By Value, 2018-2028

Table 14:   North America Pneumonia Therapeutics Market Size. By Region, By Value (USD Million), 2018-2028

Table 15:  Europe Pneumonia Therapeutics Market Size (USD Million), By Therapeutics, By Value, 2018-2028

Table 16:   Europe Pneumonia Therapeutics Market Size (USD Million), By Drug Class, By Value, 2018-2028

Table 17:   Europe Pneumonia Therapeutics Market Size (USD Million), By Drug Class, For Antibacterial Drugs, By Value, 2018-2028

Table 18:   Europe Pneumonia Therapeutics Market Size (USD Million), By Age Group, By Value, 2018-2028

Table 19:   Europe Pneumonia Therapeutics Market Size (USD Million), By Infection Type, By Value, 2018-2028

Table 20:   Europe Pneumonia Therapeutics Market Size (USD Million), By Distribution Channel, By Value, 2018-2028

Table 21:   Europe Pneumonia Therapeutics Market Size. By Region, By Value (USD Million), 2018-2028

Table 22:  Asia-Pacific Pneumonia Therapeutics Market Size (USD Million), By Therapeutics, By Value, 2018-2028

Table 23:   Asia-Pacific Pneumonia Therapeutics Market Size (USD Million), By Drug Class, By Value, 2018-2028

Table 24:   Asia-Pacific Pneumonia Therapeutics Market Size (USD Million), By Drug Class, For Antibacterial Drugs, By Value, 2018-2028

Table 25:   Asia-Pacific Pneumonia Therapeutics Market Size (USD Million), By Age Group, By Value, 2018-2028

Table 26:   Asia-Pacific Pneumonia Therapeutics Market Size (USD Million), By Infection Type, By Value, 2018-2028

Table 27:   Asia-Pacific Pneumonia Therapeutics Market Size (USD Million), By Distribution Channel, By Value, 2018-2028

Table 28:   Asia-Pacific Pneumonia Therapeutics Market Size. By Region, By Value (USD Million), 2018-2028

Table 29:  Latin America Pneumonia Therapeutics Market Size (USD Million), By Therapeutics, By Value, 2018-2028

Table 30:   Latin America Pneumonia Therapeutics Market Size (USD Million), By Drug Class, By Value, 2018-2028

Table 31:   Latin America Pneumonia Therapeutics Market Size (USD Million), By Drug Class, For Antibacterial Drugs, By Value, 2018-2028

Table 32:   Latin America Pneumonia Therapeutics Market Size (USD Million), By Age Group, By Value, 2018-2028

Table 33:   Latin America Pneumonia Therapeutics Market Size (USD Million), By Infection Type, By Value, 2018-2028

Table 34:   Latin America Pneumonia Therapeutics Market Size (USD Million), By Distribution Channel, By Value, 2018-2028

Table 35:   Latin America Pneumonia Therapeutics Market Size. By Region, By Value (USD Million), 2018-2028

Table 36:  Middle East & Africa Pneumonia Therapeutics Market Size (USD Million), By Therapeutics, By Value, 2018-2028

Table 37:   Middle East & Africa Pneumonia Therapeutics Market Size (USD Million), By Drug Class, By Value, 2018-2028

Table 38:   Middle East & Africa Pneumonia Therapeutics Market Size (USD Million), By Drug Class, For Antibacterial Drugs, By Value, 2018-2028

Table 39:   Middle East & Africa Pneumonia Therapeutics Market Size (USD Million), By Age Group, By Value, 2018-2028

Table 40:   Middle East & Africa Pneumonia Therapeutics Market Size (USD Million), By Infection Type, By Value, 2018-2028

Table 41:   Middle East & Africa Pneumonia Therapeutics Market Size (USD Million), By Distribution Channel, By Value, 2018-2028

Table 42:   Middle East & Africa Pneumonia Therapeutics Market Size. By Region, By Value (USD Million), 2018-2028

Table 43:  Merck & Co., Inc. Company Overview

Table 44:  Merck & Co. Financial Analysis (USD Million)

Table 45:  Sanofi S.A. Company Overview

Table 46:  Sanofi S.A Financial Analysis (USD Million)

Table 47:  AstraZeneca plc Company Overview

Table 48:  AstraZeneca plc Financial Analysis (USD Million)

Table 49:  Eli Lilly and Company Overview

Table 50:  Eli Lilly and Company Financial Analysis (USD Million)

Table 51:  Teva Pharmaceutical Industries Ltd. Company Overview

Table 52:  Teva Pharmaceutical Financial Analysis (USD Million)

Table 53:  Abbvie Inc. Company Overview

Table 54:  Abbvie Inc. Financial Analysis (USD Million)

Table 55:  Novartis International AG Company Overview

Table 56:  Novartis International AG Financial Analysis (USD Million)

Table 57:  Abbott Laboratories Company Overview

Table 58:  Abbott Laboratories Financial Analysis (USD Million)

Table 59:  Bayer AG Company Overview

Table 60:  Bayer AG Financial Analysis (USD Million)

Table 61:  Pfizer Inc. Company Overview

Table 62:  Pfizer Inc. Financial Analysis (USD Million)

Table 63:  GlaxoSmithKline Plc. Limited Company Overview

Table 64:  GlaxoSmithKline Plc. Financial Analysis (USD Million)

Table 65:  Lupin Pharmaceuticals, Inc., Company Overview

Table 66:  Lupin Pharmaceuticals, Inc., Financial Analysis (USD Million)